{
    "id": 14821,
    "fullName": "GRM3 act mut",
    "impact": "unknown",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "GRM3 act mut indicates that this variant results in a gain of function in the Grm3 protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 2913,
        "geneSymbol": "GRM3",
        "terms": [
            "GRM3",
            "GLUR3",
            "GPRC1C",
            "mGlu3",
            "MGLUR3"
        ]
    },
    "variant": "act mut",
    "createDate": "12/07/2015",
    "updateDate": "07/31/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3734,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Selumetinib (AZD-6244) inhibited MEK signaling and growth of melanoma cells harboring activating mutations in GRM3 in culture (PMID: 21946352).",
            "molecularProfile": {
                "id": 15080,
                "profileName": "GRM3 act mut"
            },
            "therapy": {
                "id": 913,
                "therapyName": "Selumetinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4059,
                    "pubMedId": 21946352,
                    "title": "Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21946352"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 15080,
            "profileName": "GRM3 act mut",
            "profileTreatmentApproaches": [
                {
                    "id": 7199,
                    "name": "Selumetinib",
                    "profileName": "GRM3 act mut"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}